![Francesco Maria Lavino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco Maria Lavino
Chief Executive Officer at F2G Ltd.
Francesco Maria Lavino active positions
Companies | Position | Start | End |
---|---|---|---|
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | 2021-04-11 | - |
Chief Executive Officer | 2021-04-11 | - | |
F2g Inc. | Director/Board Member | - | - |
President | - | - |
Career history of Francesco Maria Lavino
Former positions of Francesco Maria Lavino
Companies | Position | Start | End |
---|---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | 2015-08-31 | 2017-06-30 |
CUBIST PHARMACEUTICALS INC | Sales & Marketing | 2013-11-30 | 2015-08-31 |
MERCK & CO., INC. | Director/Board Member | 2010-12-31 | 2013-10-31 |
NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 2017-07-09 | - |
Training of Francesco Maria Lavino
Università degli Studi di Napoli Federico II | Undergraduate Degree |
SDA Bocconi School of Management | Masters Business Admin |
Statistics
International
United States | 4 |
Italy | 3 |
Ireland | 2 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NABRIVA THERAPEUTICS PLC | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 3 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
F2g Inc. |